FDA Drug Application (020186) for ZIAC by TEVA WOMENS

Back to FDA Applications sponsored by TEVA WOMENS

Application Number020186
Product Number001
FormTABLET;ORAL
Dosage5MG;6.25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameZIAC
Active IngredientBISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE



Back to FDA Applications sponsored by TEVA WOMENS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.